Stockreport
Counterfeit Botox has been found in several states. Here's what consumers should know. [CNN]
Last evolus, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
Some serious symptoms – including blurred vision, difficulty swallowing, shortness of breath, difficulty lifting one's head and even hospitalizations – have been linked to the use of counterfeit Botox, the FDA said on Tuesday. “These symptoms are similar to those seen when botulinum toxin spreads to other parts of the body,” according to the FDA announcement The agency announced that it is working closely with the US Centers for Disease Control and Prevention, state health departments and manufacturers to investigate and identify these counterfeit products and remove them from the market. As of Friday, a total of 19 women from nine states – Colorado, Florida, Illinois, Kentucky, Nebraska, New Jersey, New York, Tennessee, and Washington – reported “harmful reactions” after receiving Botox injections from unlicensed or untrained individuals or in places that were not health care settings, such as homes or spas, according to the CDC . The patients were between 25 and 59 years old.
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | EOLS | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
EOLS alerts
EOLS alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
EOLS alerts
High impacting Evolus, Inc. news events
Weekly update
A roundup of the hottest topics
EOLS
NEWS
NEWS
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)[Business Wire]
- Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year[Business Wire]
- Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.[MarketBeat]
- Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript [Yahoo! Finance][Yahoo! Finance]
- Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.[MarketBeat]
- More
EOLS
SEC Filings
SEC Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/26/24 - Form DEFA14A
- EOLS's page on the SEC website
- More